ArticleBMJ open diabetes research & care2025
Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort study.
Wade Thompson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.